Back to discover
Disease

Dyspepsia

Late-stage therapeutic developmentEmerging research
1
Publications
22
Clinical trials
2017
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical Milestones8View
Activity timeline8

Clinical trials

17 sponsors · 4 new · 1 completed in the last 12 months (net +4)

The current development programme across all trial phases.

Clinical programme
22
All trials
6
Active
17
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Major themes1
  • Helicobacter pylori1
Leading journals1
  • Gut1
Leading researchers8
  • Atherton J1
  • Axon AT1
  • Bazzoli F1
  • El-Omar EM1
  • Gasbarrini A1
  • Gisbert JP1
  • Graham DY1
  • Hunt R1
Affiliations (unnormalised)6
  • Erasmus University Medical Center1
  • General Infirmary Leeds1
  • Henry Dunant Hospital1
  • Hospital Universitario de La Princesa1
  • Institut für Medizinische Mikrobiologie1
  • Jichi Medical School1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Impaired digestion, especially after eating.

Identifiers
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.